Dr. Ratmir Derda, Ph.D. (Founder and Chief Executive Officer) Ratmir is an Associate Professor of Chemistry at the University of Alberta. Ratmir is the author of over 45 peer-reviewed publications and is the inventor on 10 patent applications (three issued patents). He is also an advisory board member of Organic and Biomolecular Chemistry journal, and recipient of several awards including the David Gin New Investigator Award from the American Chemical Society (2017), Marta Cook Piper Research Prize from the University of Alberta (2017), Rising Star in Chemical Biology award from International Chemical Biology Society (2015), Young Investigator Award from Boulder Peptide Society (2014) and Gold Medal at the XXIX International Chemistry Olympiad (1997). For More information Click Here
Dr. John Dwyer, Ph.D. (VP of Research): John obtained his PhD from Johns Hopkins University and did postdoctoral studies in Protein Engineering at Genentech under the supervision of Tony Kossiakoff and Jim Wells. He spent his early career at Trimeris, Inc. where his group used a combination of phage display and rational design to discover a HIV fusion inhibitor peptide that completed testing in Phase I clinical trials. He has held leadership positions at Medimmune and Pfizer, and most recently was the Director of Protein Engineering at Ferring Pharmaceuticals, where he successfully introduced chemically-modified peptide libraries and next generation sequencing into the phage display workflow. John has nearly two decades of experience in the discovery of peptide and protein biologics in the pharmaceutical setting and a proven track record of moving biologics from discovery to preclinical studies.
David Alton, MBA (Director of Business Development): David holds an MBA and from the University of Alberta. David’s career has spanned the public and private sectors. He was a senior manager in the Federal Government and later moved to the University of Alberta where he was Director of Planning for the National Institute for Nanotechnology and the Director of Business Development for the Alberta Cancer Diagnostic Consortium. David has in depth experience in starting, operating and financing new technology companies. He is a founder of four spin-off biomedical companies from the University of Alberta. David has also worked as a Management Consultant and until recently, farmed bison south of Edmonton.
Dr. Yun (Jessica) Cao, Ph.D. (Lead Data Scientist): Jessica completed her Ph.D. in Electrical and Computer Engineering from the University of Alberta under the supervision of Professor Chintha Tellambura. Shortly thereafter, she joined the Derda Research Group in August 2017 as a computing research assistant. Jessica’s research in the Derda lab focused on database design, management, web application development, data visualisation and analysis. She transitioned to 48Hour Discovery in April 2018, where she will focus on the implementation of machine learning in data analysis, and development of web-application and database.
Peter Waters, (Full Stack Developer): Peter graduated with a degree in Digital Design and Animation from West College Scotland and a degree in Software Development and Engineering from Glasgow Clyde College. Peter’s previous work experience includes being Lead Software Developer for Travel Connect, an online travel software organization in Southern Spain, and working freelance for some larger clients most notable being the Liberal Party of Canada during their 2012 party president elections. Peter joined 48Hour Discovery in July 2018.
Dr. Caishun (Carson) Li, Ph.D. (Scientist): Carson completed his Ph.D. in Molecular Biochemistry from Huazhong Agricultural University in Wuhan, China. After his Ph.D. he held a postdoctoral position at the University of Alberta under the supervision of Dr Christopher W. Cairo where he worked on T-Cell and B-Cell Membrane Glycobiology and Biophysics. He joined the Derda lab as a research assistant in 2015. Carson’s research in the Derda lab focused on screening of ligands for cell surface transporters. Shortly thereafter, he joined 48Hour Discovery INC, where he will focus on developing cell-based panning pipelines, validation of methods using genetically-encoded (GE) phage libraries and product development.
Alexey Atrazhev, PhD. (Technology Development): Alexey graduated from the Faculty of Chemistry at Moscow University, specializing in organic chemistry. He received his Ph.D. from the Engelhardt Institute of Molecular Biology under the supervision of Prof. Dr. A. Krayevsky. His doctorate was focused on the enzymology of DNA polymerases. Alexey has worked as a postdoctoral fellow and then research associate at the University of Alberta with Prof. John Elliott and Linda Pilarski. He then worked as a senior scientist at Aquila Diagnostics Inc. Alexey joined the 48Hour Discovery Team on February 1, 2019 and brings with him a wealth of experiences and knowledge. Over his career Alexey has produced 43 publications and 4 patents.
Dr. Eva Rodriguez Lopez, Ph.D. (Chemist): Eva completed her PhD in Organic Chemistry from the University of Alberta under the supervision of Dr. John Vederas. Her doctorate was focused on natural products, their synthesis and subsequent assay studies. Eva’s work experience spans academic and industry. She worked in the Research Group of Federico Gomez at the Children’s Hospital of Mexico. She then worked at Signa – Apotex Pharmachem Inc in the Research & Development Department. She joined 48Hour Discovery Inc in February 2019.
Ms Zoë O’Gara (Laboratory Technician): Zoë completed her Bachelor of Science with Honours from Dublin City University in Genetics and Cell Biology. She also completed a voluntary internship with the National Centre for Medical Genetics in Our Lady’s Children’s Hospital, Crumlin, Dublin under the supervision of Prof. David E. Barton. Her ambition to fulfill her career goals brought her to Canada where she joined 48Hour Discovery Inc in November 2018.